At present, the new treatment for membranous nephropathy is rituximab, but the best treatment program is different for different patients due to their different conditions as well as personal situations. At present, the new drug for membranous nephropathy treatment is rituximab, but not all patients are suitable for rituximab treatment, which needs to be determined according to the patient’s condition, economic status and so on. If patients with membranous nephropathy have less urine protein, they can simply apply ACEI or ARB drugs, such as Irbesartan and Valsartan. If the quantitative amount of urine protein is larger or the risk of kidney disease progression is higher, glucocorticoid plus other immunologic agents, such as prednisone, cyclophosphamide, tacrolimus, etc., and rituximab can also be applied as prescribed by the doctor for treatment. It is recommended that patients with membranous nephropathy should go to the hospital in time, improve the examination under the doctor’s guidance, evaluate the condition and make specific treatment plan.